Adcirca and Respiratory disorder - a phase IV clinical study of FDA data
Respiratory disorder is found among people who take Adcirca, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Adcirca and have Respiratory disorder. It is created by eHealthMe based on reports of 51,667 people who have side effects when taking Adcirca from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
51,667 people reported to have side effects when taking Adcirca.
Among them, 158 people (0.31%) have Respiratory disorder.
What is Adcirca?
Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 51,715 Adcirca users for its effectiveness, alternative drugs and more.
What is Respiratory disorder?
Respiratory disorder (respiratory disease) is found to be associated with 1,969 drugs and 1,519 conditions by eHealthMe.
Number of Adcirca and Respiratory disorder reports submitted per year:
Time on Adcirca when people have Respiratory disorder *:
Gender of people who have Respiratory disorder when taking Adcirca*:
Age of people who have Respiratory disorder when taking Adcirca *:
Common drugs people take besides Adcirca *:
Common side effects people have besides Respiratory disorder *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Adcirca and have Respiratory disorder?Check whether Respiratory disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Respiratory disorder and when was it recovered:
Expand to all the drugs that have ingredients of tadalafil:
Alternative drugs to, pros and cons of Adcirca:
- Adcirca (51,715 reports)
Common Adcirca side effects:
- Breathing difficulty: 9,515 reports
- Headache (pain in head): 7,648 reports
- Diarrhea: 6,014 reports
- Death: 4,159 reports
- Fatigue (feeling of tiredness): 3,869 reports
- Dizziness: 3,782 reports
- Pneumonia: 3,682 reports
- Malaise (a feeling of general discomfort or uneasiness): 3,273 reports
Browse all side effects of Adcirca:a b c d e f g h i j k l m n o p q r s t u v w x y z
Respiratory disorder treatments and more:
- Respiratory disorder (34,771 reports)
COVID vaccines that are related to Respiratory disorder:
- Respiratory disorder in Moderna COVID Vaccine
- Respiratory disorder in Pfizer BioNTech Covid Vaccine
- Respiratory disorder in Johnson and Johnson Covid Vaccine
Common drugs associated with Respiratory disorder:
- Prednisone: 3,351 reports
- Methotrexate: 2,059 reports
- Humira: 1,750 reports
- Enbrel: 1,679 reports
- Xolair: 1,359 reports
- Pantoprazole: 1,295 reports
- Symbicort: 1,261 reports
- Ibuprofen: 1,211 reports
- Tylenol: 1,189 reports
- Spiriva: 1,159 reports
All the drugs that are associated with Respiratory disorder:
- Respiratory disorder (1,969 drugs)
Common conditions associated with Respiratory disorder:
- Rheumatoid arthritis: 2,657 reports
- Asthma: 2,652 reports
- High blood pressure: 1,148 reports
- Multiple sclerosis: 976 reports
- Pain: 782 reports
- Primary pulmonary hypertension: 662 reports
All the conditions that are associated with Respiratory disorder:
- Respiratory disorder (1,519 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tadalafil (the active ingredients of Adcirca) and Adcirca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ramipril and Ticagrelor drug interaction - a second ago
- Dilaudid and Simvastatin drug interaction - 8 seconds ago
- Plan B and Pregnancy On Contraceptive - 14 seconds ago
- Mercaptopurine and Guillain-Barre Syndrome - 22 seconds ago
- Mercaptopurine and Guillain Barre Syndrome - 22 seconds ago
- Mercaptopurine and Guillain-Barré Syndrome - 22 seconds ago
- Mercaptopurine and Lactose Intolerance - 24 seconds ago
- Amoxicillin and Amidate drug interaction - 36 seconds ago
- Minocin and Inflammatory Bowel Disease - 45 seconds ago
- Glycopyrrolate and Nausea Aggravated - 47 seconds ago